| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Food Hypersensitivity | 12 | 2020 | 71 | 3.020 |
Why?
|
| Circumcision, Male | 8 | 2024 | 19 | 2.960 |
Why?
|
| Cerebral Hemorrhage | 8 | 2019 | 340 | 2.320 |
Why?
|
| Health Knowledge, Attitudes, Practice | 10 | 2018 | 533 | 2.010 |
Why?
|
| Seizures | 4 | 2018 | 306 | 1.930 |
Why?
|
| Humans | 229 | 2024 | 89357 | 1.710 |
Why?
|
| Patient Transfer | 4 | 2021 | 94 | 1.680 |
Why?
|
| Poverty | 9 | 2012 | 180 | 1.680 |
Why?
|
| Quality Improvement | 14 | 2024 | 451 | 1.520 |
Why?
|
| Communication | 13 | 2022 | 460 | 1.490 |
Why?
|
| Child | 62 | 2024 | 7174 | 1.470 |
Why?
|
| Intrauterine Devices | 3 | 2014 | 28 | 1.380 |
Why?
|
| Parents | 8 | 2017 | 285 | 1.380 |
Why?
|
| Public Health | 3 | 2023 | 138 | 1.370 |
Why?
|
| United States | 54 | 2024 | 6989 | 1.350 |
Why?
|
| Stroke | 9 | 2023 | 986 | 1.310 |
Why?
|
| Female | 125 | 2024 | 46202 | 1.300 |
Why?
|
| Patient Harm | 3 | 2018 | 7 | 1.270 |
Why?
|
| Patient Care Team | 7 | 2023 | 284 | 1.260 |
Why?
|
| Infant, Newborn | 30 | 2024 | 2486 | 1.180 |
Why?
|
| Mothers | 4 | 2017 | 142 | 1.170 |
Why?
|
| Male | 109 | 2024 | 42411 | 1.160 |
Why?
|
| Tissue Plasminogen Activator | 6 | 2022 | 171 | 1.150 |
Why?
|
| Child, Preschool | 37 | 2024 | 3731 | 1.140 |
Why?
|
| Anticonvulsants | 2 | 2018 | 125 | 1.110 |
Why?
|
| Labor, Induced | 4 | 2011 | 30 | 1.100 |
Why?
|
| Liver Transplantation | 13 | 2021 | 1180 | 1.100 |
Why?
|
| Emergency Medical Services | 6 | 2022 | 238 | 1.090 |
Why?
|
| Intensive Care Units | 7 | 2023 | 396 | 1.070 |
Why?
|
| Social Welfare | 3 | 2012 | 19 | 1.070 |
Why?
|
| Postoperative Complications | 16 | 2024 | 2284 | 1.040 |
Why?
|
| Caregivers | 9 | 2022 | 160 | 1.020 |
Why?
|
| Quality of Life | 8 | 2023 | 1668 | 1.010 |
Why?
|
| Ambulatory Care Facilities | 4 | 2018 | 111 | 1.010 |
Why?
|
| Adolescent | 44 | 2024 | 9263 | 1.010 |
Why?
|
| Aftercare | 5 | 2023 | 87 | 1.000 |
Why?
|
| Intensive Care Units, Pediatric | 2 | 2020 | 104 | 0.990 |
Why?
|
| Adult | 72 | 2024 | 26607 | 0.980 |
Why?
|
| Time-to-Treatment | 3 | 2021 | 114 | 0.980 |
Why?
|
| Safety Management | 6 | 2019 | 56 | 0.950 |
Why?
|
| Infant | 29 | 2023 | 3160 | 0.940 |
Why?
|
| General Practitioners | 1 | 2023 | 11 | 0.910 |
Why?
|
| Disorders of Sex Development | 3 | 2017 | 18 | 0.880 |
Why?
|
| Emergency Service, Hospital | 14 | 2023 | 521 | 0.870 |
Why?
|
| Stress, Psychological | 5 | 2019 | 322 | 0.850 |
Why?
|
| Health Services Accessibility | 11 | 2020 | 428 | 0.850 |
Why?
|
| Child Welfare | 4 | 2010 | 38 | 0.840 |
Why?
|
| Tuberculosis | 5 | 2022 | 121 | 0.840 |
Why?
|
| Chicago | 12 | 2023 | 1427 | 0.810 |
Why?
|
| Risk Assessment | 15 | 2023 | 2303 | 0.800 |
Why?
|
| Rehabilitation Centers | 1 | 2021 | 8 | 0.790 |
Why?
|
| Insurance Coverage | 7 | 2023 | 120 | 0.790 |
Why?
|
| Patient Discharge | 9 | 2024 | 320 | 0.770 |
Why?
|
| Mycobacterium tuberculosis | 5 | 2022 | 195 | 0.760 |
Why?
|
| Physicians | 7 | 2023 | 690 | 0.750 |
Why?
|
| Illinois | 13 | 2022 | 480 | 0.750 |
Why?
|
| Shift Work Schedule | 1 | 2020 | 6 | 0.750 |
Why?
|
| Stroke Rehabilitation | 1 | 2021 | 41 | 0.740 |
Why?
|
| Patient Education as Topic | 4 | 2018 | 360 | 0.730 |
Why?
|
| Middle Aged | 66 | 2024 | 25974 | 0.730 |
Why?
|
| Retrospective Studies | 38 | 2024 | 9057 | 0.730 |
Why?
|
| Surgical Procedures, Operative | 7 | 2024 | 206 | 0.720 |
Why?
|
| Infant Food | 1 | 2020 | 11 | 0.710 |
Why?
|
| Mobile Applications | 3 | 2018 | 70 | 0.710 |
Why?
|
| Patient Compliance | 3 | 2015 | 231 | 0.700 |
Why?
|
| Operating Rooms | 3 | 2015 | 129 | 0.690 |
Why?
|
| Quality of Health Care | 12 | 2017 | 385 | 0.690 |
Why?
|
| Patient Handoff | 3 | 2015 | 95 | 0.680 |
Why?
|
| Airway Management | 1 | 2020 | 48 | 0.680 |
Why?
|
| Surgeons | 2 | 2023 | 248 | 0.680 |
Why?
|
| Cardiovascular Diseases | 3 | 2021 | 711 | 0.670 |
Why?
|
| Insurance, Liability | 3 | 2016 | 10 | 0.670 |
Why?
|
| Allergens | 2 | 2020 | 183 | 0.670 |
Why?
|
| Tissue and Organ Procurement | 5 | 2018 | 347 | 0.660 |
Why?
|
| Medical Errors | 9 | 2016 | 117 | 0.660 |
Why?
|
| Healthcare Disparities | 5 | 2020 | 420 | 0.660 |
Why?
|
| Absenteeism | 1 | 2019 | 10 | 0.660 |
Why?
|
| Work Performance | 1 | 2019 | 4 | 0.660 |
Why?
|
| Intubation, Intratracheal | 1 | 2020 | 148 | 0.650 |
Why?
|
| Workplace | 1 | 2019 | 29 | 0.650 |
Why?
|
| Pediatrics | 8 | 2024 | 353 | 0.640 |
Why?
|
| Product Labeling | 1 | 2018 | 3 | 0.640 |
Why?
|
| Occupational Health | 1 | 2019 | 36 | 0.640 |
Why?
|
| Fund Raising | 1 | 2018 | 2 | 0.630 |
Why?
|
| Pandemics | 2 | 2021 | 773 | 0.630 |
Why?
|
| Industry | 1 | 2018 | 17 | 0.630 |
Why?
|
| Transplants | 1 | 2018 | 41 | 0.610 |
Why?
|
| Digestive System Surgical Procedures | 4 | 2024 | 127 | 0.610 |
Why?
|
| Insurance, Health | 9 | 2020 | 162 | 0.600 |
Why?
|
| Residence Characteristics | 4 | 2018 | 202 | 0.600 |
Why?
|
| Mental Health Services | 1 | 2018 | 57 | 0.600 |
Why?
|
| HIV-1 | 3 | 2024 | 166 | 0.590 |
Why?
|
| HIV Infections | 5 | 2024 | 840 | 0.590 |
Why?
|
| Cross-Sectional Studies | 14 | 2024 | 1714 | 0.590 |
Why?
|
| Quality Indicators, Health Care | 6 | 2019 | 146 | 0.590 |
Why?
|
| Perioperative Care | 2 | 2019 | 170 | 0.580 |
Why?
|
| Electronic Health Records | 6 | 2024 | 347 | 0.580 |
Why?
|
| Guidelines as Topic | 1 | 2018 | 160 | 0.570 |
Why?
|
| Infertility | 1 | 2017 | 38 | 0.570 |
Why?
|
| Prospective Studies | 19 | 2022 | 4289 | 0.570 |
Why?
|
| Fertility Preservation | 1 | 2017 | 23 | 0.570 |
Why?
|
| Wireless Technology | 2 | 2014 | 21 | 0.560 |
Why?
|
| Aged | 45 | 2024 | 19165 | 0.560 |
Why?
|
| Anemia, Sickle Cell | 4 | 2022 | 144 | 0.560 |
Why?
|
| Young Adult | 23 | 2024 | 6312 | 0.550 |
Why?
|
| Focus Groups | 11 | 2023 | 172 | 0.550 |
Why?
|
| Obstetrics | 2 | 2009 | 123 | 0.540 |
Why?
|
| Wounds and Injuries | 3 | 2024 | 259 | 0.540 |
Why?
|
| Drug Prescriptions | 5 | 2020 | 144 | 0.540 |
Why?
|
| Medically Uninsured | 10 | 2005 | 59 | 0.540 |
Why?
|
| Informed Consent | 2 | 2018 | 275 | 0.540 |
Why?
|
| Cohort Studies | 16 | 2024 | 2872 | 0.530 |
Why?
|
| Vaccination | 2 | 2023 | 274 | 0.530 |
Why?
|
| Hydroxyurea | 3 | 2022 | 239 | 0.530 |
Why?
|
| Analgesics, Opioid | 5 | 2023 | 444 | 0.530 |
Why?
|
| Patient-Centered Care | 1 | 2018 | 207 | 0.530 |
Why?
|
| Interprofessional Relations | 3 | 2015 | 122 | 0.520 |
Why?
|
| Healthcare Failure Mode and Effect Analysis | 1 | 2015 | 1 | 0.520 |
Why?
|
| Hospitals, Community | 1 | 2015 | 32 | 0.520 |
Why?
|
| Trauma Centers | 4 | 2024 | 146 | 0.510 |
Why?
|
| Bacteremia | 1 | 2016 | 102 | 0.510 |
Why?
|
| Medical Staff, Hospital | 2 | 2013 | 108 | 0.500 |
Why?
|
| Employee Performance Appraisal | 1 | 2015 | 4 | 0.500 |
Why?
|
| Teacher Training | 1 | 2015 | 2 | 0.500 |
Why?
|
| Cross Infection | 1 | 2016 | 147 | 0.490 |
Why?
|
| Practice Patterns, Physicians' | 8 | 2021 | 601 | 0.490 |
Why?
|
| Pain, Postoperative | 5 | 2023 | 252 | 0.490 |
Why?
|
| Hospitals | 5 | 2023 | 299 | 0.480 |
Why?
|
| Pregnancy | 14 | 2023 | 3018 | 0.480 |
Why?
|
| Health Education | 2 | 2013 | 105 | 0.480 |
Why?
|
| Ischemia | 3 | 2015 | 251 | 0.470 |
Why?
|
| Gestational Age | 4 | 2017 | 329 | 0.470 |
Why?
|
| Academic Medical Centers | 2 | 2023 | 385 | 0.470 |
Why?
|
| Family Practice | 2 | 2016 | 82 | 0.470 |
Why?
|
| Mental Disorders | 1 | 2018 | 414 | 0.470 |
Why?
|
| Reproductive Health Services | 1 | 2014 | 20 | 0.470 |
Why?
|
| Health Surveys | 4 | 2012 | 240 | 0.460 |
Why?
|
| Patient Safety | 6 | 2017 | 218 | 0.460 |
Why?
|
| Health Literacy | 1 | 2015 | 73 | 0.460 |
Why?
|
| Contraceptive Agents, Female | 1 | 2014 | 31 | 0.460 |
Why?
|
| Malpractice | 4 | 2017 | 57 | 0.460 |
Why?
|
| Family Planning Services | 1 | 2014 | 38 | 0.460 |
Why?
|
| Appointments and Schedules | 1 | 2014 | 54 | 0.460 |
Why?
|
| Patient Admission | 2 | 2015 | 114 | 0.450 |
Why?
|
| Counseling | 3 | 2017 | 164 | 0.450 |
Why?
|
| Comprehension | 2 | 2015 | 81 | 0.450 |
Why?
|
| Tissue Donors | 7 | 2014 | 494 | 0.450 |
Why?
|
| Mali | 9 | 2024 | 9 | 0.450 |
Why?
|
| Herpesvirus 4, Human | 2 | 2012 | 119 | 0.450 |
Why?
|
| Health Status | 6 | 2019 | 371 | 0.450 |
Why?
|
| Coinfection | 2 | 2024 | 61 | 0.440 |
Why?
|
| Urinary Tract Infections | 3 | 2019 | 76 | 0.440 |
Why?
|
| Health Care Costs | 7 | 2020 | 235 | 0.440 |
Why?
|
| Hepatitis B | 2 | 2024 | 76 | 0.440 |
Why?
|
| Multiplex Polymerase Chain Reaction | 2 | 2024 | 35 | 0.430 |
Why?
|
| C-Reactive Protein | 4 | 2018 | 192 | 0.430 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2013 | 66 | 0.430 |
Why?
|
| Employment | 2 | 2012 | 53 | 0.420 |
Why?
|
| Decision Making | 2 | 2021 | 667 | 0.420 |
Why?
|
| Attitude of Health Personnel | 4 | 2015 | 645 | 0.420 |
Why?
|
| Attitude to Health | 2 | 2017 | 222 | 0.410 |
Why?
|
| Kidney Transplantation | 6 | 2018 | 850 | 0.410 |
Why?
|
| Pregnancy Complications | 3 | 2015 | 345 | 0.410 |
Why?
|
| Rural Health | 1 | 2012 | 21 | 0.410 |
Why?
|
| Patient Preference | 3 | 2018 | 111 | 0.410 |
Why?
|
| Hematoma, Subdural | 2 | 2023 | 25 | 0.410 |
Why?
|
| Preventive Health Services | 1 | 2012 | 39 | 0.410 |
Why?
|
| Qualitative Research | 9 | 2023 | 296 | 0.410 |
Why?
|
| Elective Surgical Procedures | 5 | 2021 | 126 | 0.410 |
Why?
|
| Triage | 4 | 2023 | 111 | 0.410 |
Why?
|
| Wearable Electronic Devices | 2 | 2023 | 26 | 0.400 |
Why?
|
| Urban Health | 1 | 2012 | 56 | 0.400 |
Why?
|
| Population Density | 1 | 2012 | 61 | 0.400 |
Why?
|
| Pain Management | 4 | 2023 | 138 | 0.400 |
Why?
|
| Work | 1 | 2011 | 15 | 0.400 |
Why?
|
| Pregnant Women | 3 | 2016 | 41 | 0.390 |
Why?
|
| Opioid-Related Disorders | 3 | 2019 | 189 | 0.380 |
Why?
|
| Surveys and Questionnaires | 11 | 2020 | 2624 | 0.380 |
Why?
|
| Commerce | 2 | 2021 | 31 | 0.380 |
Why?
|
| Time Factors | 14 | 2024 | 5338 | 0.380 |
Why?
|
| Risk Factors | 15 | 2024 | 5499 | 0.370 |
Why?
|
| Patient Participation | 2 | 2017 | 224 | 0.370 |
Why?
|
| Logistic Models | 8 | 2018 | 1213 | 0.360 |
Why?
|
| Portasystemic Shunt, Transjugular Intrahepatic | 5 | 2002 | 43 | 0.360 |
Why?
|
| Cesarean Section | 2 | 2011 | 142 | 0.360 |
Why?
|
| Energy Intake | 3 | 2019 | 97 | 0.360 |
Why?
|
| Parenteral Nutrition | 3 | 2019 | 63 | 0.360 |
Why?
|
| Perception | 3 | 2021 | 179 | 0.360 |
Why?
|
| Enteral Nutrition | 3 | 2019 | 102 | 0.360 |
Why?
|
| Clinical Competence | 6 | 2024 | 784 | 0.360 |
Why?
|
| Tuberculosis, Pulmonary | 2 | 2022 | 58 | 0.350 |
Why?
|
| Mycobacterium | 2 | 2020 | 18 | 0.350 |
Why?
|
| Health Services | 6 | 2000 | 57 | 0.350 |
Why?
|
| Laparoscopy | 4 | 2020 | 773 | 0.350 |
Why?
|
| Internet | 7 | 2018 | 319 | 0.350 |
Why?
|
| Kidney Failure, Chronic | 4 | 2018 | 414 | 0.350 |
Why?
|
| Patient Readmission | 5 | 2023 | 352 | 0.340 |
Why?
|
| Resilience, Psychological | 1 | 2010 | 31 | 0.340 |
Why?
|
| Myocardial Infarction | 1 | 2013 | 374 | 0.340 |
Why?
|
| Medicaid | 3 | 2020 | 232 | 0.340 |
Why?
|
| Risk Reduction Behavior | 1 | 2010 | 96 | 0.340 |
Why?
|
| Women's Health | 1 | 2010 | 102 | 0.340 |
Why?
|
| Fibrinolytic Agents | 3 | 2022 | 217 | 0.340 |
Why?
|
| Continuity of Patient Care | 2 | 2009 | 172 | 0.340 |
Why?
|
| Public Opinion | 1 | 2009 | 42 | 0.340 |
Why?
|
| Health Personnel | 2 | 2021 | 215 | 0.330 |
Why?
|
| Sensitivity and Specificity | 4 | 2024 | 2015 | 0.330 |
Why?
|
| Medication Systems, Hospital | 1 | 2009 | 7 | 0.330 |
Why?
|
| Public Policy | 2 | 2009 | 52 | 0.330 |
Why?
|
| Inflammatory Bowel Diseases | 3 | 2022 | 580 | 0.320 |
Why?
|
| Medication Errors | 1 | 2009 | 39 | 0.320 |
Why?
|
| Prescription Drugs | 1 | 2009 | 36 | 0.320 |
Why?
|
| Rhinitis | 2 | 2022 | 179 | 0.320 |
Why?
|
| Cystography | 2 | 2019 | 6 | 0.310 |
Why?
|
| Longitudinal Studies | 7 | 2024 | 1072 | 0.310 |
Why?
|
| Severity of Illness Index | 6 | 2017 | 1840 | 0.310 |
Why?
|
| Sinusitis | 2 | 2022 | 215 | 0.310 |
Why?
|
| Infant, Very Low Birth Weight | 2 | 2018 | 52 | 0.300 |
Why?
|
| Patient Selection | 3 | 2024 | 684 | 0.300 |
Why?
|
| Waiting Lists | 4 | 2018 | 184 | 0.300 |
Why?
|
| Prevalence | 7 | 2024 | 1243 | 0.300 |
Why?
|
| Delivery of Health Care | 3 | 2022 | 435 | 0.290 |
Why?
|
| Hepatitis B virus | 2 | 2024 | 44 | 0.290 |
Why?
|
| Quality Assurance, Health Care | 3 | 2016 | 225 | 0.290 |
Why?
|
| Premature Birth | 1 | 2009 | 117 | 0.290 |
Why?
|
| Medicare | 3 | 2023 | 425 | 0.290 |
Why?
|
| Pregnancy Trimester, Third | 3 | 2016 | 70 | 0.290 |
Why?
|
| Gastrointestinal Microbiome | 3 | 2024 | 509 | 0.290 |
Why?
|
| Blood Specimen Collection | 1 | 2007 | 27 | 0.280 |
Why?
|
| Exercise | 3 | 2024 | 323 | 0.280 |
Why?
|
| Infant, Low Birth Weight | 1 | 2007 | 58 | 0.280 |
Why?
|
| Socioeconomic Factors | 8 | 2016 | 588 | 0.280 |
Why?
|
| Chronic Disease | 7 | 2022 | 950 | 0.280 |
Why?
|
| Asthma | 3 | 2013 | 978 | 0.280 |
Why?
|
| Thrombolytic Therapy | 3 | 2022 | 232 | 0.280 |
Why?
|
| Interdisciplinary Communication | 3 | 2021 | 131 | 0.280 |
Why?
|
| Patient Outcome Assessment | 4 | 2021 | 84 | 0.280 |
Why?
|
| Bacteria | 2 | 2021 | 478 | 0.280 |
Why?
|
| Ascites | 3 | 2001 | 56 | 0.280 |
Why?
|
| Community Health Workers | 1 | 2007 | 33 | 0.270 |
Why?
|
| Decision Support Systems, Clinical | 2 | 2019 | 105 | 0.270 |
Why?
|
| Hospitalization | 7 | 2023 | 877 | 0.270 |
Why?
|
| Treatment Outcome | 14 | 2020 | 8241 | 0.270 |
Why?
|
| School Health Services | 1 | 2006 | 16 | 0.270 |
Why?
|
| Health Facilities | 2 | 2023 | 36 | 0.270 |
Why?
|
| Program Evaluation | 10 | 2018 | 307 | 0.260 |
Why?
|
| Self Administration | 1 | 2006 | 72 | 0.260 |
Why?
|
| Child Health Services | 4 | 2006 | 48 | 0.260 |
Why?
|
| Lithotripsy | 9 | 2001 | 45 | 0.260 |
Why?
|
| Brain Ischemia | 2 | 2022 | 400 | 0.250 |
Why?
|
| Guideline Adherence | 4 | 2024 | 230 | 0.250 |
Why?
|
| Biomarkers | 4 | 2018 | 1767 | 0.250 |
Why?
|
| Contraception | 2 | 2018 | 93 | 0.250 |
Why?
|
| Public Assistance | 1 | 2005 | 6 | 0.250 |
Why?
|
| Health Benefit Plans, Employee | 1 | 2005 | 10 | 0.250 |
Why?
|
| Multivariate Analysis | 8 | 2018 | 988 | 0.250 |
Why?
|
| Aged, 80 and over | 14 | 2021 | 6811 | 0.240 |
Why?
|
| Age Factors | 5 | 2021 | 1870 | 0.240 |
Why?
|
| Interviews as Topic | 6 | 2024 | 339 | 0.240 |
Why?
|
| Interleukin-10 | 2 | 2022 | 151 | 0.240 |
Why?
|
| Subarachnoid Hemorrhage | 2 | 2015 | 138 | 0.240 |
Why?
|
| Genome, Viral | 1 | 2024 | 81 | 0.240 |
Why?
|
| Intensive Care Units, Neonatal | 3 | 2019 | 72 | 0.240 |
Why?
|
| Critical Care | 2 | 2023 | 382 | 0.230 |
Why?
|
| Task Performance and Analysis | 2 | 2015 | 87 | 0.230 |
Why?
|
| Hypertension, Portal | 2 | 2001 | 46 | 0.230 |
Why?
|
| Communication Barriers | 4 | 2021 | 30 | 0.230 |
Why?
|
| Viral Load | 1 | 2024 | 145 | 0.230 |
Why?
|
| Cholelithiasis | 8 | 2001 | 35 | 0.230 |
Why?
|
| Pediatricians | 1 | 2023 | 17 | 0.230 |
Why?
|
| Urologists | 1 | 2023 | 29 | 0.220 |
Why?
|
| Dysbiosis | 1 | 2024 | 78 | 0.220 |
Why?
|
| Consciousness | 1 | 2023 | 28 | 0.220 |
Why?
|
| Self Report | 5 | 2022 | 297 | 0.220 |
Why?
|
| Referral and Consultation | 3 | 2022 | 341 | 0.220 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2024 | 282 | 0.220 |
Why?
|
| Ownership | 1 | 2023 | 26 | 0.220 |
Why?
|
| HIV Integrase | 1 | 2023 | 5 | 0.220 |
Why?
|
| Income | 2 | 2017 | 84 | 0.220 |
Why?
|
| Organizational Culture | 3 | 2019 | 32 | 0.220 |
Why?
|
| Frail Elderly | 1 | 2024 | 82 | 0.220 |
Why?
|
| Length of Stay | 3 | 2024 | 736 | 0.220 |
Why?
|
| Hospitals, Urban | 1 | 2023 | 60 | 0.220 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2023 | 27 | 0.220 |
Why?
|
| Goals | 1 | 2023 | 67 | 0.210 |
Why?
|
| HIV Seropositivity | 1 | 2023 | 51 | 0.210 |
Why?
|
| Research Report | 2 | 2021 | 44 | 0.210 |
Why?
|
| Hospitals, Pediatric | 4 | 2021 | 117 | 0.210 |
Why?
|
| Liver Cirrhosis | 4 | 2017 | 256 | 0.210 |
Why?
|
| Multicenter Studies as Topic | 2 | 2020 | 155 | 0.210 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2023 | 48 | 0.210 |
Why?
|
| Polymorphism, Genetic | 3 | 2023 | 825 | 0.210 |
Why?
|
| Registries | 4 | 2018 | 784 | 0.210 |
Why?
|
| Databases, Factual | 3 | 2023 | 856 | 0.210 |
Why?
|
| Antisickling Agents | 1 | 2022 | 4 | 0.210 |
Why?
|
| Hypertension | 2 | 2019 | 745 | 0.210 |
Why?
|
| Emergency Medical Dispatcher | 1 | 2022 | 2 | 0.210 |
Why?
|
| Frailty | 1 | 2024 | 76 | 0.200 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2021 | 2661 | 0.200 |
Why?
|
| Coronavirus | 1 | 2022 | 18 | 0.200 |
Why?
|
| Biosensing Techniques | 1 | 2023 | 73 | 0.200 |
Why?
|
| Health Plan Implementation | 2 | 2019 | 56 | 0.200 |
Why?
|
| Ethics Committees, Research | 1 | 2022 | 33 | 0.200 |
Why?
|
| State Health Plans | 3 | 2014 | 14 | 0.200 |
Why?
|
| Interrupted Time Series Analysis | 1 | 2021 | 8 | 0.200 |
Why?
|
| Acute Disease | 4 | 2022 | 841 | 0.200 |
Why?
|
| Emergency Medical Service Communication Systems | 2 | 2022 | 6 | 0.200 |
Why?
|
| Odds Ratio | 3 | 2020 | 683 | 0.200 |
Why?
|
| Liver Function Tests | 1 | 2001 | 92 | 0.200 |
Why?
|
| Immunoglobulin E | 2 | 2020 | 145 | 0.190 |
Why?
|
| Mycobacterium Infections, Nontuberculous | 1 | 2021 | 27 | 0.190 |
Why?
|
| Kidney Function Tests | 1 | 2001 | 114 | 0.190 |
Why?
|
| Genotype | 3 | 2024 | 1849 | 0.190 |
Why?
|
| Attitude | 2 | 2017 | 130 | 0.190 |
Why?
|
| Allied Health Personnel | 1 | 2021 | 20 | 0.190 |
Why?
|
| Colectomy | 2 | 2020 | 172 | 0.190 |
Why?
|
| Living Donors | 2 | 2018 | 339 | 0.190 |
Why?
|
| Palliative Care | 1 | 2023 | 264 | 0.190 |
Why?
|
| Models, Statistical | 2 | 2017 | 576 | 0.190 |
Why?
|
| Employer Health Costs | 1 | 2020 | 1 | 0.190 |
Why?
|
| Follow-Up Studies | 14 | 2017 | 3666 | 0.190 |
Why?
|
| Medication Adherence | 2 | 2022 | 140 | 0.190 |
Why?
|
| Papillomavirus Infections | 1 | 2024 | 261 | 0.190 |
Why?
|
| Terminology as Topic | 2 | 2017 | 221 | 0.190 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2021 | 73 | 0.190 |
Why?
|
| Natural Language Processing | 1 | 2021 | 38 | 0.180 |
Why?
|
| Incidence | 5 | 2018 | 1595 | 0.180 |
Why?
|
| Organ Transplantation | 2 | 2016 | 276 | 0.180 |
Why?
|
| Education, Distance | 1 | 2020 | 25 | 0.180 |
Why?
|
| Birth Weight | 2 | 2017 | 148 | 0.180 |
Why?
|
| Base Pairing | 1 | 2020 | 56 | 0.180 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2022 | 93 | 0.180 |
Why?
|
| Mycobacterium Infections | 1 | 2020 | 15 | 0.180 |
Why?
|
| Therapy, Computer-Assisted | 1 | 2019 | 17 | 0.170 |
Why?
|
| Urethra | 2 | 2019 | 115 | 0.170 |
Why?
|
| Desensitization, Immunologic | 1 | 2020 | 37 | 0.170 |
Why?
|
| Motivation | 1 | 2022 | 296 | 0.170 |
Why?
|
| Evaluation Studies as Topic | 2 | 2019 | 270 | 0.170 |
Why?
|
| Cognition | 3 | 2021 | 580 | 0.170 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2022 | 2340 | 0.170 |
Why?
|
| Safety | 3 | 2012 | 149 | 0.170 |
Why?
|
| Probability | 3 | 2009 | 353 | 0.170 |
Why?
|
| Hemostatics | 1 | 2019 | 57 | 0.170 |
Why?
|
| Recovery of Function | 1 | 2021 | 293 | 0.170 |
Why?
|
| Students | 2 | 2013 | 170 | 0.170 |
Why?
|
| Telephone | 2 | 2021 | 35 | 0.170 |
Why?
|
| Ambulatory Care | 5 | 2022 | 187 | 0.170 |
Why?
|
| Global Health | 1 | 2020 | 187 | 0.170 |
Why?
|
| Dietary Supplements | 1 | 2020 | 125 | 0.160 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2022 | 296 | 0.160 |
Why?
|
| Private Sector | 1 | 2019 | 19 | 0.160 |
Why?
|
| Uterine Diseases | 1 | 2019 | 19 | 0.160 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2022 | 223 | 0.160 |
Why?
|
| New York | 9 | 2000 | 72 | 0.160 |
Why?
|
| Professional-Family Relations | 1 | 2019 | 54 | 0.160 |
Why?
|
| Cooperative Behavior | 2 | 2017 | 179 | 0.160 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2020 | 838 | 0.160 |
Why?
|
| Dietary Proteins | 1 | 2018 | 30 | 0.160 |
Why?
|
| Telemedicine | 1 | 2021 | 188 | 0.160 |
Why?
|
| Genetic Association Studies | 1 | 2020 | 294 | 0.160 |
Why?
|
| Data Warehousing | 1 | 2018 | 4 | 0.160 |
Why?
|
| Long-Acting Reversible Contraception | 1 | 2018 | 12 | 0.160 |
Why?
|
| Diabetic Ketoacidosis | 1 | 2018 | 14 | 0.160 |
Why?
|
| Anti-Bacterial Agents | 3 | 2022 | 788 | 0.160 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2014 | 260 | 0.160 |
Why?
|
| Neurosurgical Procedures | 1 | 2020 | 232 | 0.160 |
Why?
|
| Liability, Legal | 2 | 2009 | 32 | 0.150 |
Why?
|
| Competency-Based Education | 1 | 2018 | 36 | 0.150 |
Why?
|
| Contraception Behavior | 1 | 2018 | 28 | 0.150 |
Why?
|
| Gastrostomy | 1 | 2018 | 70 | 0.150 |
Why?
|
| Hernia, Ventral | 1 | 2018 | 25 | 0.150 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2017 | 19 | 0.150 |
Why?
|
| Smoking | 2 | 2022 | 621 | 0.150 |
Why?
|
| Models, Theoretical | 3 | 2016 | 491 | 0.150 |
Why?
|
| Death | 2 | 2023 | 85 | 0.150 |
Why?
|
| Pregnancy Trimester, Second | 2 | 2015 | 69 | 0.150 |
Why?
|
| Stakeholder Participation | 1 | 2017 | 22 | 0.150 |
Why?
|
| Hysterectomy | 1 | 2019 | 151 | 0.150 |
Why?
|
| Growth Disorders | 1 | 2017 | 63 | 0.150 |
Why?
|
| Community Participation | 2 | 2017 | 38 | 0.150 |
Why?
|
| Nutritional Status | 1 | 2017 | 80 | 0.150 |
Why?
|
| Breast Neoplasms | 2 | 2023 | 3011 | 0.150 |
Why?
|
| Urography | 1 | 2017 | 45 | 0.150 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2020 | 414 | 0.150 |
Why?
|
| HLA Antigens | 1 | 2019 | 227 | 0.150 |
Why?
|
| Knee Joint | 1 | 2018 | 165 | 0.150 |
Why?
|
| Labor Pain | 1 | 2017 | 6 | 0.150 |
Why?
|
| Immune Tolerance | 1 | 2020 | 339 | 0.150 |
Why?
|
| Urology | 1 | 2019 | 117 | 0.150 |
Why?
|
| Analgesia, Obstetrical | 1 | 2017 | 21 | 0.140 |
Why?
|
| Regression Analysis | 5 | 2009 | 590 | 0.140 |
Why?
|
| Chorioamnionitis | 1 | 2017 | 21 | 0.140 |
Why?
|
| Weight Gain | 1 | 2017 | 119 | 0.140 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2018 | 110 | 0.140 |
Why?
|
| User-Computer Interface | 1 | 2018 | 187 | 0.140 |
Why?
|
| Phenytoin | 1 | 2016 | 15 | 0.140 |
Why?
|
| Clinical Trials as Topic | 2 | 2024 | 1150 | 0.140 |
Why?
|
| Practice Patterns, Nurses' | 1 | 2016 | 3 | 0.140 |
Why?
|
| Piracetam | 1 | 2016 | 8 | 0.140 |
Why?
|
| Urologic Diseases | 1 | 2017 | 44 | 0.140 |
Why?
|
| Herniorrhaphy | 1 | 2018 | 91 | 0.140 |
Why?
|
| Specialties, Surgical | 1 | 2017 | 66 | 0.140 |
Why?
|
| Resource Allocation | 1 | 2017 | 65 | 0.140 |
Why?
|
| Bile Duct Diseases | 3 | 2011 | 22 | 0.140 |
Why?
|
| National Institute of Child Health and Human Development (U.S.) | 1 | 2016 | 3 | 0.140 |
Why?
|
| Nurse Practitioners | 1 | 2016 | 30 | 0.140 |
Why?
|
| Critical Illness | 1 | 2019 | 306 | 0.140 |
Why?
|
| End Stage Liver Disease | 1 | 2017 | 60 | 0.140 |
Why?
|
| Brain Death | 3 | 2012 | 82 | 0.140 |
Why?
|
| Osteoarthritis, Knee | 1 | 2016 | 66 | 0.130 |
Why?
|
| Community-Institutional Relations | 1 | 2016 | 29 | 0.130 |
Why?
|
| Health Behavior | 2 | 2018 | 185 | 0.130 |
Why?
|
| Craniotomy | 1 | 2016 | 88 | 0.130 |
Why?
|
| Biomedical Research | 1 | 2020 | 398 | 0.130 |
Why?
|
| Cognitive Dysfunction | 1 | 2018 | 146 | 0.130 |
Why?
|
| Colorectal Surgery | 1 | 2016 | 22 | 0.130 |
Why?
|
| Transition to Adult Care | 1 | 2016 | 22 | 0.130 |
Why?
|
| Machine Learning | 1 | 2018 | 258 | 0.130 |
Why?
|
| Chronic Pain | 1 | 2018 | 162 | 0.130 |
Why?
|
| Otolaryngology | 1 | 2016 | 55 | 0.130 |
Why?
|
| Iatrogenic Disease | 2 | 2007 | 70 | 0.130 |
Why?
|
| Respiratory Tract Infections | 1 | 2016 | 106 | 0.130 |
Why?
|
| Video Recording | 2 | 2015 | 203 | 0.130 |
Why?
|
| Hospital Administration | 1 | 2015 | 26 | 0.130 |
Why?
|
| Anxiety | 2 | 2015 | 308 | 0.130 |
Why?
|
| Child Development | 2 | 2016 | 167 | 0.130 |
Why?
|
| Mobility Limitation | 1 | 2015 | 20 | 0.130 |
Why?
|
| Choice Behavior | 1 | 2016 | 160 | 0.130 |
Why?
|
| Research Design | 1 | 2019 | 599 | 0.130 |
Why?
|
| Pancreas Transplantation | 1 | 2015 | 104 | 0.120 |
Why?
|
| Diagnostic Imaging | 2 | 2017 | 479 | 0.120 |
Why?
|
| Hyperparathyroidism, Primary | 1 | 2015 | 42 | 0.120 |
Why?
|
| Parathyroidectomy | 1 | 2015 | 77 | 0.120 |
Why?
|
| Hydrocortisone | 1 | 2016 | 302 | 0.120 |
Why?
|
| Health Status Indicators | 1 | 2015 | 103 | 0.120 |
Why?
|
| Antibodies, Viral | 2 | 2015 | 309 | 0.120 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2015 | 75 | 0.120 |
Why?
|
| Diet | 1 | 2017 | 442 | 0.120 |
Why?
|
| Risk Management | 1 | 2014 | 43 | 0.120 |
Why?
|
| Efficiency, Organizational | 1 | 2014 | 59 | 0.120 |
Why?
|
| Drug Implants | 1 | 2014 | 34 | 0.120 |
Why?
|
| Diagnostic Errors | 1 | 2015 | 160 | 0.120 |
Why?
|
| Postoperative Care | 1 | 2015 | 231 | 0.120 |
Why?
|
| Internal Medicine | 1 | 2018 | 355 | 0.120 |
Why?
|
| Heart-Lung Transplantation | 2 | 1993 | 19 | 0.110 |
Why?
|
| Risk Adjustment | 1 | 2014 | 38 | 0.110 |
Why?
|
| Treatment Failure | 2 | 2013 | 287 | 0.110 |
Why?
|
| Videoconferencing | 1 | 2013 | 15 | 0.110 |
Why?
|
| Mental Health | 1 | 2015 | 178 | 0.110 |
Why?
|
| Health Care Surveys | 2 | 2016 | 280 | 0.110 |
Why?
|
| Physician-Patient Relations | 1 | 2019 | 625 | 0.110 |
Why?
|
| Information Dissemination | 1 | 2014 | 114 | 0.110 |
Why?
|
| Community-Based Participatory Research | 1 | 2013 | 37 | 0.110 |
Why?
|
| Pneumonectomy | 1 | 2015 | 207 | 0.110 |
Why?
|
| Simulation Training | 1 | 2015 | 97 | 0.110 |
Why?
|
| Chorionic Villi | 1 | 2012 | 11 | 0.110 |
Why?
|
| Decidua | 1 | 2012 | 19 | 0.110 |
Why?
|
| Child Abuse | 2 | 2004 | 84 | 0.110 |
Why?
|
| Shellfish | 1 | 2012 | 4 | 0.110 |
Why?
|
| Cost of Illness | 1 | 2013 | 147 | 0.110 |
Why?
|
| Family Health | 2 | 2013 | 162 | 0.100 |
Why?
|
| Health Policy | 1 | 2014 | 185 | 0.100 |
Why?
|
| Decision Support Techniques | 1 | 2014 | 167 | 0.100 |
Why?
|
| Professional Practice | 1 | 2012 | 46 | 0.100 |
Why?
|
| Self Care | 1 | 2013 | 165 | 0.100 |
Why?
|
| Health Promotion | 1 | 2013 | 165 | 0.100 |
Why?
|
| Patient Reported Outcome Measures | 2 | 2023 | 192 | 0.100 |
Why?
|
| Cardiac Catheterization | 1 | 2013 | 303 | 0.090 |
Why?
|
| Delivery Rooms | 1 | 2010 | 2 | 0.090 |
Why?
|
| Patient Care Planning | 2 | 2023 | 83 | 0.090 |
Why?
|
| Personnel Management | 1 | 2010 | 7 | 0.090 |
Why?
|
| General Surgery | 1 | 2013 | 236 | 0.090 |
Why?
|
| Stress, Physiological | 1 | 2012 | 232 | 0.090 |
Why?
|
| Hospital Mortality | 2 | 2023 | 387 | 0.090 |
Why?
|
| Obstetric Labor, Premature | 1 | 2011 | 58 | 0.090 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2011 | 52 | 0.090 |
Why?
|
| Bacterial Typing Techniques | 2 | 2022 | 28 | 0.090 |
Why?
|
| Esophageal and Gastric Varices | 2 | 2002 | 34 | 0.090 |
Why?
|
| Education | 2 | 2009 | 58 | 0.090 |
Why?
|
| Adolescent Behavior | 2 | 2006 | 109 | 0.090 |
Why?
|
| Delivery, Obstetric | 1 | 2010 | 118 | 0.090 |
Why?
|
| Social Isolation | 1 | 2010 | 67 | 0.090 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2010 | 55 | 0.090 |
Why?
|
| Data Collection | 2 | 2009 | 375 | 0.090 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 2018 | 0.090 |
Why?
|
| Tape Recording | 1 | 2009 | 19 | 0.090 |
Why?
|
| Poisson Distribution | 1 | 2009 | 50 | 0.090 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 2758 | 0.090 |
Why?
|
| Birth Certificates | 1 | 2009 | 7 | 0.080 |
Why?
|
| Analgesics | 2 | 2023 | 119 | 0.080 |
Why?
|
| Reproduction | 1 | 2010 | 199 | 0.080 |
Why?
|
| Databases as Topic | 1 | 2009 | 94 | 0.080 |
Why?
|
| Gastrointestinal Hemorrhage | 3 | 2002 | 237 | 0.080 |
Why?
|
| Internship and Residency | 1 | 2018 | 1045 | 0.080 |
Why?
|
| Hospital Charges | 1 | 2008 | 29 | 0.080 |
Why?
|
| Quality Control | 1 | 2009 | 117 | 0.080 |
Why?
|
| Child Behavior Disorders | 2 | 2001 | 76 | 0.080 |
Why?
|
| Drug Utilization | 1 | 2009 | 66 | 0.080 |
Why?
|
| Hepatectomy | 1 | 2009 | 170 | 0.080 |
Why?
|
| Food Supply | 1 | 2008 | 29 | 0.080 |
Why?
|
| Confidence Intervals | 1 | 2008 | 225 | 0.080 |
Why?
|
| Child Behavior | 2 | 2006 | 47 | 0.080 |
Why?
|
| Schools | 1 | 2008 | 76 | 0.080 |
Why?
|
| Critical Pathways | 2 | 2019 | 37 | 0.080 |
Why?
|
| Postoperative Period | 2 | 2021 | 302 | 0.070 |
Why?
|
| Adaptation, Psychological | 2 | 2007 | 166 | 0.070 |
Why?
|
| Pilot Projects | 2 | 2024 | 871 | 0.070 |
Why?
|
| Poverty Areas | 1 | 2007 | 37 | 0.070 |
Why?
|
| Graft Survival | 3 | 2015 | 900 | 0.070 |
Why?
|
| Heart Arrest | 1 | 2010 | 279 | 0.070 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2015 | 1120 | 0.070 |
Why?
|
| Adolescent Health Services | 1 | 2006 | 11 | 0.070 |
Why?
|
| Parental Consent | 1 | 2006 | 35 | 0.070 |
Why?
|
| Home Care Services | 1 | 2007 | 73 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 3 | 2019 | 1047 | 0.070 |
Why?
|
| Histocompatibility Testing | 2 | 2019 | 137 | 0.070 |
Why?
|
| Preoperative Care | 1 | 2008 | 396 | 0.060 |
Why?
|
| Urban Population | 1 | 2007 | 224 | 0.060 |
Why?
|
| Aid to Families with Dependent Children | 1 | 2005 | 4 | 0.060 |
Why?
|
| Prognosis | 3 | 2018 | 3783 | 0.060 |
Why?
|
| Africa, Western | 1 | 2024 | 11 | 0.060 |
Why?
|
| Anti-Retroviral Agents | 1 | 2024 | 32 | 0.060 |
Why?
|
| Personnel Turnover | 1 | 2024 | 9 | 0.060 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 1723 | 0.060 |
Why?
|
| Midwestern United States | 1 | 2024 | 82 | 0.060 |
Why?
|
| Preoperative Period | 2 | 2014 | 94 | 0.060 |
Why?
|
| Gallbladder Emptying | 2 | 1994 | 4 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 2415 | 0.060 |
Why?
|
| Corticotropin-Releasing Hormone | 2 | 2015 | 44 | 0.060 |
Why?
|
| Parenting | 1 | 2004 | 69 | 0.060 |
Why?
|
| Developing Countries | 1 | 2024 | 77 | 0.060 |
Why?
|
| Clinical Protocols | 1 | 2024 | 157 | 0.060 |
Why?
|
| Hypotension | 1 | 2024 | 71 | 0.060 |
Why?
|
| Problem Solving | 2 | 2022 | 54 | 0.060 |
Why?
|
| Adrenocorticotropic Hormone | 2 | 2015 | 131 | 0.060 |
Why?
|
| Outpatients | 1 | 2024 | 100 | 0.060 |
Why?
|
| Research Personnel | 1 | 2024 | 71 | 0.060 |
Why?
|
| DNA, Viral | 1 | 2024 | 262 | 0.060 |
Why?
|
| DNA Primers | 1 | 2024 | 543 | 0.060 |
Why?
|
| Resuscitation | 1 | 2024 | 109 | 0.060 |
Why?
|
| Health Planning Guidelines | 1 | 2003 | 22 | 0.060 |
Why?
|
| Exercise Therapy | 1 | 2024 | 81 | 0.060 |
Why?
|
| Glasgow Coma Scale | 1 | 2023 | 73 | 0.060 |
Why?
|
| Cote d'Ivoire | 1 | 2023 | 2 | 0.060 |
Why?
|
| Renal Dialysis | 2 | 2018 | 335 | 0.050 |
Why?
|
| Feasibility Studies | 2 | 2016 | 780 | 0.050 |
Why?
|
| RNA, Viral | 1 | 2024 | 317 | 0.050 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2023 | 23 | 0.050 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2015 | 492 | 0.050 |
Why?
|
| Primary Health Care | 3 | 2001 | 351 | 0.050 |
Why?
|
| Monitoring, Physiologic | 2 | 2023 | 266 | 0.050 |
Why?
|
| S-Adenosylmethionine | 1 | 2023 | 15 | 0.050 |
Why?
|
| Seroepidemiologic Studies | 1 | 2023 | 54 | 0.050 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2008 | 475 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2022 | 2401 | 0.050 |
Why?
|
| Health Services Research | 3 | 2013 | 137 | 0.050 |
Why?
|
| Homocysteine | 1 | 2023 | 30 | 0.050 |
Why?
|
| HIV | 1 | 2023 | 48 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 2015 | 2362 | 0.050 |
Why?
|
| Methionine | 1 | 2023 | 65 | 0.050 |
Why?
|
| Hematoma | 1 | 2023 | 108 | 0.050 |
Why?
|
| Injury Severity Score | 1 | 2023 | 143 | 0.050 |
Why?
|
| Linear Models | 1 | 2023 | 421 | 0.050 |
Why?
|
| Sputum | 1 | 2022 | 35 | 0.050 |
Why?
|
| Anesthetics, Local | 1 | 2023 | 76 | 0.050 |
Why?
|
| Fetal Hemoglobin | 1 | 2022 | 14 | 0.050 |
Why?
|
| Reoperation | 2 | 2018 | 599 | 0.050 |
Why?
|
| Anti-HIV Agents | 1 | 2024 | 159 | 0.050 |
Why?
|
| Minisatellite Repeats | 1 | 2022 | 24 | 0.050 |
Why?
|
| Organizational Innovation | 1 | 2022 | 41 | 0.050 |
Why?
|
| Antitubercular Agents | 1 | 2022 | 54 | 0.050 |
Why?
|
| Utah | 3 | 2007 | 9 | 0.050 |
Why?
|
| Colorado | 3 | 2007 | 37 | 0.050 |
Why?
|
| Language | 1 | 2023 | 154 | 0.050 |
Why?
|
| Molecular Epidemiology | 1 | 2022 | 53 | 0.050 |
Why?
|
| Diffusion of Innovation | 1 | 2022 | 71 | 0.050 |
Why?
|
| Ursodeoxycholic Acid | 3 | 1997 | 25 | 0.050 |
Why?
|
| Patients | 1 | 2022 | 102 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 2 | 2016 | 461 | 0.050 |
Why?
|
| Fatty Acids, Volatile | 1 | 2021 | 32 | 0.050 |
Why?
|
| Hemodynamics | 1 | 2024 | 731 | 0.050 |
Why?
|
| Paracentesis | 1 | 2000 | 10 | 0.050 |
Why?
|
| Inpatients | 1 | 2023 | 310 | 0.050 |
Why?
|
| Publication Bias | 1 | 2020 | 13 | 0.050 |
Why?
|
| Hospitals, Maternity | 1 | 2020 | 2 | 0.050 |
Why?
|
| Endoscopy | 2 | 2002 | 350 | 0.040 |
Why?
|
| Genetic Heterogeneity | 1 | 2020 | 63 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2023 | 427 | 0.040 |
Why?
|
| Neonatologists | 1 | 2019 | 6 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2022 | 326 | 0.040 |
Why?
|
| Pain | 1 | 2022 | 400 | 0.040 |
Why?
|
| California | 1 | 2020 | 144 | 0.040 |
Why?
|
| Activities of Daily Living | 1 | 2021 | 207 | 0.040 |
Why?
|
| Social Class | 1 | 2020 | 136 | 0.040 |
Why?
|
| Developmental Disabilities | 1 | 2001 | 202 | 0.040 |
Why?
|
| Proportional Hazards Models | 3 | 2015 | 851 | 0.040 |
Why?
|
| Geography | 1 | 2020 | 227 | 0.040 |
Why?
|
| Fluid Therapy | 1 | 2019 | 51 | 0.040 |
Why?
|
| North America | 1 | 2019 | 184 | 0.040 |
Why?
|
| Sodium | 2 | 2017 | 331 | 0.040 |
Why?
|
| Early Diagnosis | 1 | 2019 | 125 | 0.040 |
Why?
|
| Organ Dysfunction Scores | 1 | 2019 | 27 | 0.040 |
Why?
|
| Women's Health Services | 1 | 2019 | 14 | 0.040 |
Why?
|
| Medical Oncology | 1 | 2023 | 383 | 0.040 |
Why?
|
| Urination | 1 | 2019 | 37 | 0.040 |
Why?
|
| Life Support Care | 1 | 2019 | 50 | 0.040 |
Why?
|
| Phylogeny | 1 | 2024 | 1187 | 0.040 |
Why?
|
| Genomics | 1 | 2024 | 762 | 0.040 |
Why?
|
| Food, Fortified | 1 | 2018 | 15 | 0.040 |
Why?
|
| Health Expenditures | 1 | 2000 | 91 | 0.040 |
Why?
|
| Haplotypes | 1 | 2020 | 637 | 0.040 |
Why?
|
| Feces | 1 | 2020 | 330 | 0.040 |
Why?
|
| Culturally Competent Care | 1 | 2018 | 12 | 0.040 |
Why?
|
| Datasets as Topic | 1 | 2018 | 75 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2019 | 895 | 0.040 |
Why?
|
| Dietary Carbohydrates | 1 | 2017 | 39 | 0.040 |
Why?
|
| Age Distribution | 2 | 2011 | 200 | 0.040 |
Why?
|
| Medical Audit | 3 | 2005 | 39 | 0.040 |
Why?
|
| Immunization Programs | 1 | 1997 | 24 | 0.040 |
Why?
|
| Program Development | 1 | 2018 | 123 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2018 | 371 | 0.040 |
Why?
|
| Sexual Development | 1 | 2017 | 1 | 0.040 |
Why?
|
| Adjuvants, Pharmaceutic | 1 | 1997 | 5 | 0.040 |
Why?
|
| Body Height | 1 | 2017 | 100 | 0.040 |
Why?
|
| Ambulances | 1 | 2017 | 15 | 0.040 |
Why?
|
| Body Size | 1 | 2017 | 92 | 0.040 |
Why?
|
| Parturition | 1 | 2017 | 21 | 0.040 |
Why?
|
| Dietary Fats | 1 | 2017 | 135 | 0.040 |
Why?
|
| Species Specificity | 1 | 2019 | 684 | 0.040 |
Why?
|
| Head | 1 | 2017 | 137 | 0.040 |
Why?
|
| Professional-Patient Relations | 1 | 2017 | 54 | 0.040 |
Why?
|
| Mass Screening | 1 | 2001 | 636 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2019 | 685 | 0.030 |
Why?
|
| Disease Progression | 1 | 2021 | 1489 | 0.030 |
Why?
|
| Kidney | 2 | 2000 | 1147 | 0.030 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2017 | 77 | 0.030 |
Why?
|
| Birth Rate | 1 | 2016 | 12 | 0.030 |
Why?
|
| Episode of Care | 1 | 2016 | 7 | 0.030 |
Why?
|
| Pituitary-Adrenal System | 1 | 2016 | 64 | 0.030 |
Why?
|
| Radiography | 1 | 2018 | 809 | 0.030 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2016 | 81 | 0.030 |
Why?
|
| Educational Measurement | 1 | 2018 | 231 | 0.030 |
Why?
|
| Survival Analysis | 3 | 2011 | 1534 | 0.030 |
Why?
|
| Cost Savings | 1 | 2016 | 69 | 0.030 |
Why?
|
| Saliva | 1 | 2016 | 124 | 0.030 |
Why?
|
| Group Processes | 1 | 2015 | 31 | 0.030 |
Why?
|
| Grounded Theory | 1 | 2015 | 7 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1862 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2019 | 900 | 0.030 |
Why?
|
| World Health Organization | 1 | 2016 | 106 | 0.030 |
Why?
|
| Obesity | 1 | 2022 | 971 | 0.030 |
Why?
|
| Infant, Premature | 1 | 2017 | 298 | 0.030 |
Why?
|
| Observational Studies as Topic | 1 | 2015 | 49 | 0.030 |
Why?
|
| Sexual Behavior | 1 | 2018 | 311 | 0.030 |
Why?
|
| Leadership | 1 | 2016 | 138 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2022 | 1374 | 0.030 |
Why?
|
| Personal Satisfaction | 1 | 2015 | 63 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2020 | 945 | 0.030 |
Why?
|
| Checklist | 1 | 2015 | 61 | 0.030 |
Why?
|
| Morbidity | 1 | 1995 | 149 | 0.030 |
Why?
|
| Risk | 1 | 2016 | 657 | 0.030 |
Why?
|
| Regional Health Planning | 1 | 2014 | 13 | 0.030 |
Why?
|
| Cold Ischemia | 1 | 2014 | 18 | 0.030 |
Why?
|
| State Government | 1 | 2014 | 22 | 0.030 |
Why?
|
| Policy Making | 1 | 2014 | 62 | 0.030 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2015 | 487 | 0.030 |
Why?
|
| Environmental Health | 1 | 2013 | 8 | 0.030 |
Why?
|
| Social Marketing | 1 | 2013 | 11 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2016 | 305 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 461 | 0.030 |
Why?
|
| Tissue Preservation | 1 | 1993 | 14 | 0.030 |
Why?
|
| Curriculum | 1 | 2018 | 568 | 0.030 |
Why?
|
| Cardioplegic Solutions | 1 | 1993 | 17 | 0.030 |
Why?
|
| Organ Preservation Solutions | 1 | 1993 | 28 | 0.030 |
Why?
|
| Solutions | 1 | 1993 | 86 | 0.030 |
Why?
|
| Physician's Role | 1 | 1995 | 177 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 860 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2018 | 560 | 0.030 |
Why?
|
| Skin Tests | 1 | 2012 | 44 | 0.030 |
Why?
|
| Violence | 1 | 1995 | 153 | 0.030 |
Why?
|
| Decision Trees | 1 | 2012 | 59 | 0.030 |
Why?
|
| Cardiopulmonary Bypass | 1 | 1993 | 157 | 0.030 |
Why?
|
| Markov Chains | 1 | 2012 | 127 | 0.030 |
Why?
|
| Maternal Age | 1 | 2011 | 45 | 0.020 |
Why?
|
| Mutation | 1 | 2023 | 4143 | 0.020 |
Why?
|
| Physician-Nurse Relations | 1 | 2010 | 2 | 0.020 |
Why?
|
| Obstetrics and Gynecology Department, Hospital | 1 | 2010 | 4 | 0.020 |
Why?
|
| Depression | 1 | 2015 | 505 | 0.020 |
Why?
|
| Health Records, Personal | 1 | 2010 | 12 | 0.020 |
Why?
|
| Biliary Tract Diseases | 1 | 2011 | 36 | 0.020 |
Why?
|
| Primary Graft Dysfunction | 1 | 2011 | 39 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2021 | 3385 | 0.020 |
Why?
|
| Renal Insufficiency | 1 | 2011 | 98 | 0.020 |
Why?
|
| Hepatitis C, Chronic | 1 | 2011 | 91 | 0.020 |
Why?
|
| Cause of Death | 1 | 2011 | 269 | 0.020 |
Why?
|
| Liver Regeneration | 1 | 2009 | 36 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2018 | 1176 | 0.020 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2010 | 78 | 0.020 |
Why?
|
| Health Resources | 1 | 2010 | 81 | 0.020 |
Why?
|
| Hospital Costs | 1 | 2010 | 109 | 0.020 |
Why?
|
| Intraoperative Complications | 1 | 1990 | 188 | 0.020 |
Why?
|
| Total Quality Management | 1 | 2008 | 33 | 0.020 |
Why?
|
| Heart Transplantation | 1 | 1993 | 717 | 0.020 |
Why?
|
| Inflammation | 1 | 2012 | 972 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2011 | 394 | 0.020 |
Why?
|
| Psychometrics | 1 | 2008 | 330 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2009 | 773 | 0.020 |
Why?
|
| Graft Rejection | 1 | 2011 | 1070 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2011 | 758 | 0.010 |
Why?
|
| Parent-Child Relations | 1 | 2004 | 79 | 0.010 |
Why?
|
| Survival Rate | 2 | 2002 | 1901 | 0.010 |
Why?
|
| Epidemiologic Research Design | 1 | 2003 | 22 | 0.010 |
Why?
|
| Recurrence | 2 | 2000 | 1144 | 0.010 |
Why?
|
| Ligation | 1 | 2002 | 51 | 0.010 |
Why?
|
| Chi-Square Distribution | 2 | 1994 | 360 | 0.010 |
Why?
|
| Relative Value Scales | 1 | 2001 | 9 | 0.010 |
Why?
|
| Models, Economic | 1 | 2001 | 62 | 0.010 |
Why?
|
| Secondary Prevention | 1 | 2002 | 158 | 0.010 |
Why?
|
| Reference Values | 1 | 2002 | 661 | 0.010 |
Why?
|
| Insurance Benefits | 1 | 2000 | 8 | 0.010 |
Why?
|
| Hepatic Encephalopathy | 1 | 2000 | 39 | 0.010 |
Why?
|
| Eligibility Determination | 1 | 2000 | 36 | 0.010 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2001 | 157 | 0.010 |
Why?
|
| Combined Modality Therapy | 2 | 1994 | 1719 | 0.010 |
Why?
|
| Renin | 1 | 1998 | 67 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 1998 | 306 | 0.010 |
Why?
|
| Emergencies | 1 | 1998 | 121 | 0.010 |
Why?
|
| Retreatment | 1 | 1997 | 108 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1997 | 899 | 0.010 |
Why?
|
| Social Problems | 1 | 1995 | 10 | 0.010 |
Why?
|
| Life Tables | 1 | 1994 | 48 | 0.010 |
Why?
|
| Mass Media | 1 | 1995 | 26 | 0.010 |
Why?
|
| Domestic Violence | 1 | 1995 | 24 | 0.010 |
Why?
|
| Firearms | 1 | 1995 | 69 | 0.010 |
Why?
|
| Hypertonic Solutions | 1 | 1993 | 17 | 0.010 |
Why?
|
| Raffinose | 1 | 1993 | 23 | 0.010 |
Why?
|
| Procaine | 1 | 1993 | 11 | 0.010 |
Why?
|
| Body Water | 1 | 1993 | 35 | 0.010 |
Why?
|
| Potassium Chloride | 1 | 1993 | 86 | 0.010 |
Why?
|
| Heart Arrest, Induced | 1 | 1993 | 30 | 0.010 |
Why?
|
| Mannitol | 1 | 1993 | 50 | 0.010 |
Why?
|
| Positive-Pressure Respiration | 1 | 1993 | 41 | 0.010 |
Why?
|
| Cholecystokinin | 1 | 1993 | 15 | 0.010 |
Why?
|
| Papio | 1 | 1993 | 82 | 0.010 |
Why?
|
| Allopurinol | 1 | 1993 | 77 | 0.010 |
Why?
|
| Glutathione | 1 | 1993 | 108 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 1997 | 1719 | 0.010 |
Why?
|
| Catecholamines | 1 | 1993 | 92 | 0.010 |
Why?
|
| Cardiac Output | 1 | 1993 | 156 | 0.010 |
Why?
|
| ROC Curve | 1 | 1994 | 781 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1994 | 712 | 0.010 |
Why?
|
| Actuarial Analysis | 1 | 1991 | 66 | 0.010 |
Why?
|
| Bile Acids and Salts | 1 | 1991 | 66 | 0.010 |
Why?
|
| Stroke Volume | 1 | 1993 | 463 | 0.010 |
Why?
|
| Substance-Related Disorders | 1 | 1995 | 415 | 0.010 |
Why?
|
| Adenosine | 1 | 1993 | 238 | 0.010 |
Why?
|
| Chenodeoxycholic Acid | 1 | 1990 | 7 | 0.010 |
Why?
|
| Glucose | 1 | 1993 | 630 | 0.010 |
Why?
|
| Myocardium | 1 | 1993 | 571 | 0.010 |
Why?
|
| Ventricular Function, Left | 1 | 1993 | 605 | 0.010 |
Why?
|
| Insulin | 1 | 1993 | 1146 | 0.000 |
Why?
|
| Lung | 1 | 1993 | 1263 | 0.000 |
Why?
|
| Animals | 1 | 1993 | 27371 | 0.000 |
Why?
|